Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in Am J Clin Pathol

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    May 2018
  1. LANDMANN A, Farrugia DJ, Zhu L, Diego EJ, et al
    Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Am J Clin Pathol. 2018 May 8. pii: 4993844. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  2. CLARK BZ, Farrugia DJ, Landmann A, Diego EJ, et al
    Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.
    Am J Clin Pathol. 2018 Feb 22. pii: 4899077. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. KHOURY T
    Delay to Formalin Fixation (Cold Ischemia Time) Effect on Breast Cancer Molecules.
    Am J Clin Pathol. 2018 Feb 19. pii: 4874188. doi: 10.1093.
    PubMed     Text format     Abstract available


    November 2017
  4. SHIN ET, Joehlin-Price AS, Agnese DM, Zynger DL, et al
    Minimal Clinical Impact of Intraoperative Examination of Sentinel Lymph Nodes in Patients With Ductal Carcinoma In Situ: An Opportunity for Improved Resource Utilization.
    Am J Clin Pathol. 2017;148:374-379.
    PubMed     Text format     Abstract available


    October 2017
  5. GULBAHCE HE
    Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference Laboratory.
    Am J Clin Pathol. 2017;148:308-313.
    PubMed     Text format     Abstract available


    September 2017
  6. LIN CY, Carneal EE, Lichtensztajn DY, Gomez SL, et al
    Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks.
    Am J Clin Pathol. 2017;148:199-207.
    PubMed     Text format     Abstract available


  7. KUBA MG, Lester SC, Giess CS, Bertagnolli MM, et al
    Fibromatosis of the Breast: Diagnostic Accuracy of Core Needle Biopsy.
    Am J Clin Pathol. 2017;148:243-250.
    PubMed     Text format     Abstract available


    August 2017
  8. KHOURY T, Zirpoli G, Cohen SM, Geradts J, et al
    Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.
    Am J Clin Pathol. 2017;148:108-118.
    PubMed     Text format     Abstract available


  9. HOU Y, Zynger DL, Li X, Li Z, et al
    Comparison of Oncotype DX With Modified Magee Equation Recurrence Scores in Low-Grade Invasive Carcinoma of Breast.
    Am J Clin Pathol. 2017;148:167-172.
    PubMed     Text format     Abstract available


    April 2017
  10. BHARGAVA R, Florea AV, Pelmus M, Jones MW, et al
    Breast Tumor Resembling Tall Cell Variant of Papillary Thyroid Carcinoma: A Solid Papillary Neoplasm With Characteristic Immunohistochemical Profile and Few Recurrent Mutations.
    Am J Clin Pathol. 2017;147:399-410.
    PubMed     Text format     Abstract available


    March 2017
  11. SOLOMON JP, Dell'Aquila M, Fadare O, Hasteh F, et al
    Her2/neu Status Determination in Breast Cancer: A Single Institutional Experience Using a Dual-Testing Approach With Immunohistochemistry and Fluorescence In Situ Hybridization.
    Am J Clin Pathol. 2017 Mar 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. LIN D, Genzen J
    Comparison of Breast Cancer Tumor Marker Test Results: A Retrospective Analysis of Paired CA 15-3 and CA 27.29 Testing at a National Reference Laboratory.
    Am J Clin Pathol. 2017 Mar 1. doi: 10.1093.
    PubMed     Text format    


    January 2017
  13. SERDY KM, Leone JP, Dabbs DJ, Bhargava R, et al
    Male Breast Cancer: A Single-Institution Clinicopathologic and Immunohistochemical Study.
    Am J Clin Pathol. 2017 Jan 24. pii: aqw207. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. HOU Y, Nitta H, Li Z
    HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer.
    Am J Clin Pathol. 2017 Jan 21. pii: aqw211. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. SERDY KM, Leone JP, Dabbs DJ, Bhargava R, et al
    Male Breast Cancer.
    Am J Clin Pathol. 2017;147:110-119.
    PubMed     Text format    


    October 2016
  16. SHEN T, Zhang K, Siegal GP, Wei S, et al
    Prognostic Value of E-Cadherin and beta-Catenin in Triple-Negative Breast Cancer.
    Am J Clin Pathol. 2016.
    PubMed     Text format     Abstract available


  17. LI X, Wetherilt CS, Krishnamurti U, Yang J, et al
    Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer.
    Am J Clin Pathol. 2016;146:496-502.
    PubMed     Text format     Abstract available


    September 2016
  18. SHAO T, Wood M, Wing A, Hnatovska M, et al
    Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer: A Cohort Study Emphasizing Equivocal Cases.
    Am J Clin Pathol. 2016;146:339-45.
    PubMed     Text format     Abstract available


    June 2016
  19. LI XB, Krishnamurti U, Bhattarai S, Klimov S, et al
    Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Am J Clin Pathol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: